Dr. Parsons is a physician-scientist with more than 20 years of experience in designing, executing, and leading clinical trials in the private and public sectors. He has expertise in all phases of bench-to-beside biomedical research and is an author on over 190 scientific publications appearing in JAMA, the New England Journal of Medicine, Journal of Clinical Oncology, and others. He has served on national committees for the American Society of Clinical Oncology, National Comprehensive Cancer Network (Committee Co-chair), and American Urological Association (Committee Chair); in national leadership positions within the National Cancer Institute clinical trials network; and on the editorial boards of three medical journals. Prior to joining MBrace, he was Senior Medical Director at Janssen R&D. In this role, he supervised an international Phase 3 registrational oncology trial of 2,400 patients, co-led the development of a novel Phase 3 registrational study and corresponding Type C FDA interaction, and advised on Phase 1 through 3 clinical trial designs across the oncology solid tumor portfolio. Prior to Janssen, Dr. Parsons was an endowed Professor and Head of Urologic Oncology at the Moores UC San Diego Comprehensive Cancer Center. Dr. Parsons completed his residency in urologic surgery and fellowship in urologic oncology at the Johns Hopkins Hospital. He received his M.H.S. in Clinical Investigation from the Johns Hopkins Bloomberg School of Public Health, M.D. from the University of Pennsylvania, and A.B. in History from Stanford University.